Already a member? Sign in
Category: Prescription Drugs
Orencia® is a brand name for abatacept, a disease modifying antirheumatic drug used for adult rheumatoid arthritis (RA) as a monotherapy or in combination with other disease modifying antirheumatic drug; also used as monotherapy or in combination with methotrexate for juvenile idiopathic arthritis.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| RA (Rheumatoid Arthritis) | 23 | 5 |
|
|
|
||
| Rheumatoid Arthritis | 3 | 1 |
|
||||
| Transplant rejection prevention | 2 | 1 |
|
||||
| CIDP (Chronic inflammatory demyelinating polyneuropathy) | 1 | 0 | |||||
| Reactive Arthritis | 1 | 0 | |||||
| Psoriatic Arthritis | 1 | 0 |
See all 32 patients currently taking Orencia
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Orencia
| Fatigue | 1 | |
|---|---|---|
| Dizziness | 1 | |
| Cold sensations (coldness) | 1 | |
| Nausea and vomiting | 1 | |
| Muscle and joint pain | 1 | |
| Migraine headaches | 1 |
Frequently reported dosages based on patients currently taking Orencia. See all 12 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 11 | ||
| Doctor's advice | 6 | ||
| Change in health plan coverage | 2 | ||
| Other | 2 | ||
| Side effects too severe | 1 | ||
| Expense | 1 | ||
| Course of treatment ended | 1 | ||
| Personal research | 1 |
Adherence
Taking treatment as prescribed
Adherence of Orencia
Always |
6 | 100% |
|
|---|---|---|---|
Usually |
0 | 0% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Orencia
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
1 | 17% |
|
A little |
2 | 33% |
|
Not at all |
3 | 50% |
|
Cost
Paid out of pocket
Cost of Orencia
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
1 | 25% |
|
$50-99 |
0 | 0% |
|
$25-49 |
1 | 25% |
|
< $25 |
2 | 50% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 27, 2012.